Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00177372 · ClinicalTrials.gov registry record · Phase 4
Mifepristone and Misoprostol for Fetal Demise
A Phase 4 study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
NCT00177372 is a Phase 4 study that has completed, run by University of Pittsburgh. The registered enrollment target is 30 participants.
The verdict
NCT00177372, a Phase 4 study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
Study Summary
This is a pilot clinical trial to evaluate whether the medical management of early pregnancy failure with mifepristone and misoprostol is an effective and acceptable treatment. Subjects with early pregnancy failure receive mifepristone followed 24 hours later by vaginal misoprostol for medical management. Subjects then return on study day 3 for a repeat ultrasound to assess passage of pregnancy tissue. subjects who still have a gestational sac present at Day 3 receive a second dose of vaginal misoprostol. All subjects have a follow-up at Day 15, by phone for those who passed the pregnancy with the first dose of misoprostol, and in person for those who received a second dose. Questionnaires are administered at the beginning and end of the study to determine acceptability.
Interventions
- DRUG mifepristone/misoprostol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2005-01 |
| Est. Completion | 2005-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00177372
The ClinicalTrials.gov registry entry for NCT00177372 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which mifepristone/misoprostol is the first listed.
NCT00177372 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00177372 about?
NCT00177372 is a clinical study titled "Mifepristone and Misoprostol for Fetal Demise". This is a pilot clinical trial to evaluate whether the medical management of early pregnancy failure with mifepristone and misoprostol is an effective and acceptable treatment. Subjects with early pregnancy failure receive mifepristone followed 24 hours later by vaginal misoprostol for medical manag...
What is the current status of trial NCT00177372?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2005-01. Estimated completion is 2005-09.
What interventions are being tested in trial NCT00177372?
The interventions under investigation include: mifepristone/misoprostol (DRUG).
Who is sponsoring clinical trial NCT00177372?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.